The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence-Reference-Cited by-同舟云学术

The mixed-action delta/mu opioid agonist MMP-2200 does not produce conditioned place preference but does maintain drug self-administration in rats, and induces in vitro markers of tolerance and dependence

Published:2015-05 Issue: Volume:132 Page:49-55
ISSN:0091-3057
Container-title:Pharmacology Biochemistry and Behavior
language:en
Short-container-title:Pharmacology Biochemistry and Behavior

Author:

Stevenson Glenn W.,Luginbuhl Amy,Dunbar Catherine,LaVigne Justin,Dutra Julio,Atherton Phillip,Bell Brooke,Cone Katherine,Giuvelis Denise,Polt Robin,Streicher John M.,Bilsky Edward J.

Funder

University of New England

NIAMS

NIH

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry

Reference34 articles.

1. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used;Adams;J Pharmacol Exp Ther,1993

2. 14-Alkoxy- and 14-acyloxypyridomorphinans: μ agonist/δ antagonist opioid analgesics with diminished tolerance and dependence side effects;Ananthan;J Med Chem,2012

3. Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment;Avidor-Reiss;J Biol Chem,1995

4. Conditioned place preference: what does it add to our preclinical understanding of drug reward?;Bardo;Psychopharmacology (Berl),2000

5. Using antagonists to assess neurochemical coding of a drug's ability to establish a conditioned place preference;Bilsky;Pharm Biochem Behav,1990

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide-derived ligands for the discovery of safer opioid analgesics;Drug Discovery Today;2024-05

2. Design and synthesis of oxytocin glycosides for the treatment of pain and substance use disorder;Methods in Enzymology;2024

3. Identification and Pharmacological Characterization of a Low-Liability Antinociceptive Bifunctional MOR/DOR Cyclic Peptide;Molecules;2023-11-11

4. Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy;Frontiers in Pharmacology;2023-07-03

5. Mu and Delta Opioid Receptor Targeting Reduces Connexin 43-Based Heterocellular Coupling during Neuropathic Pain;International Journal of Molecular Sciences;2022-05-24